Large-scale testing (Phase 3)Ended earlyNCT06488911
What this trial is testing
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
Who this might be right for
Primary Biliary Cholangitis
Intercept Pharmaceuticals 63